Exelixis Inc (EXEL)
34.83
+0.18
(+0.52%)
USD |
NASDAQ |
Nov 21, 16:00
34.82
0.00 (0.00%)
After-Hours: 20:00
Exelixis Profit Margin (Quarterly): 21.87% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 21.87% |
| June 30, 2024 | 35.49% |
| March 31, 2024 | 8.78% |
| December 31, 2023 | 17.83% |
| September 30, 2023 | 0.22% |
| June 30, 2023 | 17.28% |
| March 31, 2023 | 9.79% |
| December 31, 2022 | -7.12% |
| September 30, 2022 | 17.78% |
| June 30, 2022 | 16.85% |
| March 31, 2022 | 19.26% |
| December 31, 2021 | 21.09% |
| September 30, 2021 | 11.63% |
| June 30, 2021 | 24.95% |
| March 31, 2021 | 0.59% |
| December 31, 2020 | 10.51% |
| September 30, 2020 | -13.86% |
| June 30, 2020 | 25.75% |
| March 31, 2020 | 21.42% |
| December 31, 2019 | 28.61% |
| September 30, 2019 | 35.87% |
| June 30, 2019 | 32.90% |
| March 31, 2019 | 35.16% |
| December 31, 2018 | |
| September 30, 2018 | 56.18% |
| Date | Value |
|---|---|
| June 30, 2018 | 47.01% |
| March 31, 2018 | 54.21% |
| December 31, 2017 | 32.05% |
| September 30, 2017 | 53.36% |
| June 30, 2017 | 17.83% |
| March 31, 2017 | 20.65% |
| December 31, 2016 | 45.27% |
| September 30, 2016 | -18.14% |
| June 30, 2016 | -96.10% |
| March 31, 2016 | -383.9% |
| December 31, 2015 | -418.3% |
| September 30, 2015 | -462.2% |
| June 30, 2015 | -542.6% |
| March 31, 2015 | -374.6% |
| December 31, 2014 | -689.6% |
| September 30, 2014 | -994.4% |
| June 30, 2014 | -1.12K% |
| March 31, 2014 | -1.52K% |
| December 31, 2013 | -1.63K% |
| September 30, 2013 | -1.23K% |
| June 30, 2013 | -524.3% |
| March 31, 2013 | -462.6% |
| December 31, 2012 | -667.9% |
| September 30, 2012 | -246.5% |
| June 30, 2012 | -467.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-13.86%
Minimum
Sep 2020
35.49%
Maximum
Jun 2024
14.44%
Average
17.53%
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 18.95% |
| ADMA Biologics Inc | 29.96% |
| Vericel Corp | -1.56% |
| Catalyst Pharmaceuticals Inc | 34.10% |
| Inovio Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.97% |
| Return on Assets | 16.15% |
| Return on Invested Capital | 20.97% |
| Gross Profit Margin (Quarterly) | 96.79% |
| Operating Margin (Quarterly) | 34.82% |
| Return on Net Operating Assets | 57.32% |